Julie R. McMullen

Professor Julie McMullen (PhD) heads the Cardiac Hypertrophy Laboratory at the Baker Heart and Diabetes Institute (VIC, AUSTRALIA) and is Head of the Discovery & Preclinical Domain at the Institute. Her research interests include physiological and pathological cardiac hypertrophy, heart failure, atrial fibrillation, gene therapy and cardiotoxicity. Prof McMullen is recognised internationally for research which defined the molecular distinction between physiological and pathological heart growth/cardiac hypertrophy in mouse models of health and disease. She discovered that a signalling pathway activated with exercise (PI3K pathway) was critical for physiological hypertrophy (e.g. athlete’s heart) but not pathological hypertrophy (e.g. setting of hypertension). She has published her research in leading journals including PNAS, Circulation, Circulation-Heart Failure, Nature Communications, Cell Reports, and Diabetes. She sits on the Editorial Board of Clinical Science and the American Journal of Physiology-Heart and Circulatory Physiology, and is a Fellow of the American Heart Association and International Society for Heart Research.